FibroGen, Inc. (FGEN)
NASDAQ: FGEN · IEX Real-Time Price · USD
1.070
-0.070 (-6.14%)
Apr 23, 2024, 4:00 PM EDT - Market closed
FibroGen Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 113.69 | 155.7 | 171.22 | 678.39 | 126.27 | 89.26 | 673.66 | 173.78 | 153.32 | 172.71 | Upgrade
|
Short-Term Investments | 121.9 | 266.31 | 233.97 | 8.14 | 407.49 | 532.14 | 62.06 | 79.4 | 27.85 | 14.36 | Upgrade
|
Cash & Cash Equivalents | 235.59 | 422.01 | 405.19 | 686.54 | 533.76 | 621.4 | 735.72 | 253.18 | 181.17 | 187.07 | Upgrade
|
Cash Growth | -44.17% | 4.15% | -40.98% | 28.62% | -14.10% | -15.54% | 190.59% | 39.75% | -3.15% | 43.83% | Upgrade
|
Receivables | 12.55 | 16.3 | 17.4 | 41.88 | 28.46 | 63.68 | 8.45 | 10.45 | 15.41 | 13.45 | Upgrade
|
Inventory | 41.57 | 40.44 | 31.02 | 16.53 | 6.89 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Current Assets | 41.86 | 14.08 | 20.45 | 10.16 | 133.39 | 4.93 | 4.8 | 2.89 | 3.99 | -2.29 | Upgrade
|
Total Current Assets | 331.56 | 492.83 | 474.06 | 755.11 | 702.49 | 690.02 | 748.97 | 266.52 | 200.56 | 198.24 | Upgrade
|
Property, Plant & Equipment | 81.22 | 100.5 | 119.39 | 65.3 | 82.35 | 127.2 | 129.48 | 123.66 | 129.02 | 132.17 | Upgrade
|
Long-Term Investments | 6.95 | 11.48 | 173.69 | 5.04 | 63.19 | 59.97 | 15.69 | 77.23 | 138.97 | 144.27 | Upgrade
|
Other Long-Term Assets | 3.8 | 5.28 | 6.68 | 1.39 | 9.37 | 3.42 | 4.52 | 2.15 | 2.02 | 8.85 | Upgrade
|
Total Long-Term Assets | 91.97 | 117.26 | 299.76 | 71.73 | 154.91 | 190.58 | 149.68 | 203.04 | 270.01 | 285.29 | Upgrade
|
Total Assets | 423.53 | 610.09 | 773.82 | 826.84 | 857.4 | 880.6 | 898.65 | 469.55 | 470.57 | 483.53 | Upgrade
|
Accounts Payable | 17.96 | 30.76 | 26.1 | 24.79 | 6.09 | 9.14 | 5.51 | 6.22 | 6.52 | 4.55 | Upgrade
|
Deferred Revenue | 170.3 | 198.46 | 202.66 | 145.02 | 99.94 | 149.88 | 154.91 | 114.7 | 97.86 | 70.21 | Upgrade
|
Current Debt | 14.08 | 10.29 | 10.94 | 13.52 | 12.35 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Current Liabilities | 15.34 | 34.05 | -14.2 | -20.14 | -15.63 | -69.99 | -74.46 | -55.8 | -37.2 | -12 | Upgrade
|
Total Current Liabilities | 217.67 | 273.56 | 225.5 | 163.19 | 102.75 | 89.03 | 85.96 | 65.13 | 67.18 | 62.75 | Upgrade
|
Long-Term Debt | 189.88 | 128.93 | 88.78 | 26.24 | 37.61 | 97.16 | 97.76 | 97.35 | 97.04 | 96.82 | Upgrade
|
Other Long-Term Liabilities | 178.18 | 209.08 | 230.44 | 195.96 | 181.64 | 165.94 | 167.19 | 131.97 | 109.53 | 83.28 | Upgrade
|
Total Long-Term Liabilities | 368.06 | 338.01 | 319.21 | 222.2 | 219.25 | 263.1 | 264.95 | 229.32 | 206.57 | 180.1 | Upgrade
|
Total Liabilities | 585.73 | 611.57 | 544.71 | 385.39 | 321.99 | 352.13 | 350.91 | 294.44 | 273.75 | 242.85 | Upgrade
|
Total Debt | 203.96 | 139.22 | 99.72 | 39.76 | 49.96 | 97.16 | 97.76 | 97.35 | 97.04 | 96.82 | Upgrade
|
Debt Growth | 46.50% | 39.61% | 150.79% | -20.41% | -48.58% | -0.62% | 0.42% | 0.32% | 0.23% | 0.01% | Upgrade
|
Retained Earnings | -1,841.92 | -1,557.69 | -1,264.03 | -974.01 | -784.72 | -715.83 | -630.66 | -469.74 | -408.06 | -322.28 | Upgrade
|
Comprehensive Income | -6.88 | -5.72 | -4.16 | -4.5 | -0.75 | -2.28 | -1.8 | -0.96 | -1.65 | -3.15 | Upgrade
|
Shareholders' Equity | -204.17 | -21.45 | 209.15 | 422.18 | 516.14 | 509.2 | 528.47 | 155.84 | 177.55 | 221.41 | Upgrade
|
Net Cash / Debt | 31.63 | 282.79 | 305.47 | 646.78 | 483.8 | 524.25 | 637.96 | 155.83 | 84.13 | 90.26 | Upgrade
|
Net Cash / Debt Growth | -88.82% | -7.42% | -52.77% | 33.69% | -7.72% | -17.82% | 309.40% | 85.22% | -6.79% | 171.41% | Upgrade
|
Net Cash Per Share | 0.33 | 3.02 | 3.31 | 7.20 | 5.58 | 6.24 | 8.74 | 2.48 | 1.39 | 4.81 | Upgrade
|
Working Capital | 113.89 | 219.26 | 248.56 | 591.92 | 599.75 | 600.98 | 663.01 | 201.39 | 133.38 | 135.48 | Upgrade
|
Book Value Per Share | -2.10 | -0.23 | 2.27 | 4.70 | 5.96 | 6.06 | 7.24 | 2.48 | 2.94 | 11.79 | Upgrade
|